The United States of America’s Food And Drug Administration (FDA) has fully authorised the Pfizer Covid-19 Vaccine. The vaccine known as the Pfizer-BioNTech Covid-19 vaccine will now be marketed under the name Comirnaty.
In a statement released by the FDA, acting FDA Commissioner Janet Woodcock believes that the approval of the Pfizer vaccine is a milestone in the battle against the Covid-19 Pandemic. She says “as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,”
Woodcock believes that the announcement made by the FDA will further reassure people that the vaccine is safe and encourge people to get vacinated against Covid-19
The Pfizer vaccine has been part of South Africa’s vaccination rollout plan since its inception. South Africans who receive the Pfizer vaccine will have to receive two jabs in order to be protected against the virus.
To determine the safety of the vaccine, the FDA conducted a clinical trial in which 22 000 people were given a jab of the vaccine while 22 000 people were given a placebo injection. The FDA collected data from trials that took place in the United States of America, the European Union, Turkey, South Africa and South America
The results of the trial found that the Pfizer vaccine was 91% effective in preventing the Covid-19 disease.Common side effects that were reported included pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills, and fever.
The FDA says the vaccine can still be administered to Covid-19 patients between the ages of 12 and 15 under emergency use authorisation (EUA).